Jörg Altekrueger

Head Drug Substance Development, Basel
Novartis
Philipp Nold
Jrg Altekrger has been dealing with biopharmaceutical drug substance process development for more than 15 years. As upstream scientist, pilot plant manager and group leader in a well-known international company he worked on the development and implementation of numerous pharmaceutical projects from early phase up to commercialisation. In the last years, he focused with the team on developing Advanced Integrated Biopharmaceutical manufacturing in lab- and manufacturing scale. Since 2018, he is responsible for the late phase Drug Substance Development site at Novartis in Basel, Switzerland. In 2003, he received his Diplom Engineer in Biotechnology from the University of Applied Science in Hamburg.

Sessions

October 29 2019, 09:00
 - 09:30
Stream Keynote Address: Advanced Integrated Biopharmaceutical Manufacturing: USP High Throughput Development From Lab Scale To Commercial Scale